Abstract
About 60% of patients with esophageal cancer have an advanced tumor at diagnosis, and for these patients neither surgery nor radiotherapy can offer anything more than palliation. This fact has led, in the past 10 years, to an increase in the number of studies of chemotherapy as a possible alternative treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kelsen D (1984) Chemotherapy of esophageal cancer. Semin Oncol 11: 159–168
Schabel EM et al. (1974) Phase-I clinical trial of combined therapy with 5-FU and cis-platin. Cancer 84: 1005–1010
Kish J et al. (1984) Cisplatin and 5-FU infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 53: 1814
Vogl SE, Zaravinos T, Kaplan BH (1980) Toxicity of cis-diamminedichloroplatinum II given in a 2-h outpatient regimen of diuresis and hydration. Cancer 45: 11–15
Fox R, Woods RL, Tattersall MHN et al. (1981) Allopurinol modulation of fluorouracil toxicity. Cancer Chemother Pharmacol 5: 151–155
Howell SB, Wung WE, Taetle E et al. (1981) Modulation of 5-fluorouracil toxicity by al-lopurinol in man. Cancer 48: 1281–1289
Hellerstein S, Rosen S, Kies M et al. (1983) Cisplatin and 5-FU combined chemotherapy of epidermoid esophageal cancer. Proc American Society of Clinical Oncology, no 2, 127
De Besi P, Salvagno L, Endrizzi L et al. (1984) Cisplatin, bleomycin and methotrexate in the treatment of advanced esophageal cancer. Eur J Cancer Clin Oncol 20: 732
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
De Besi, P. et al. (1988). Systemic Chemotherapy with Cisplatin, 5-Fluorouracil and Allopurinol in the Management of Advanced Epidermoid Esophageal Cancer. In: Schlag, P., Hohenberger, P., Metzger, U. (eds) Combined Modality Therapy of Gastrointestinal Tract Cancer. Recent Results in Cancer Research, vol 110. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83293-2_30
Download citation
DOI: https://doi.org/10.1007/978-3-642-83293-2_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83295-6
Online ISBN: 978-3-642-83293-2
eBook Packages: Springer Book Archive